Eva Chin

Eva Chin

Company: NMD Pharma

Job title: Chief Development Officer


Panel Discussion – Biggest Learnings From Failed or Abandoned Clinical Trials 9:10 am

• Scrutinizing the disconnect between preclinical to clinical translation, why were there such promising results in preclinical yet poor translation into positive clinical trials? • Why did they fail? What was the endpoint? What could have been done differently? • What were the biggest lessons learned? • What was surprising in terms of the outcome…Read more

day: Day Two

Live Q&A 5:05 pm

Read more

day: Day One

Exploring Pharmacodynamic Safety Profiles for Successful Clinical Translation 3:50 pm

• Dissecting various dosing strategies and dosing versus efficacy • Addressing translational challenges of extrapolating animal dosage predictions and demonstrating optimal doses • How can we demonstrate a clear mechanistic route between dose, mechanisms of action and endpoints? • How can we increase the probability of dosing high enough to reach efficacious concentrations and ensure…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.